Clinical Trial Update: Study of Ketamine as an Antidepressant in Major Depressive Disorder [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on ketamine as an antidepressant for Major Depressive Disorder, spanning Phase 1 and Phase 2 studies; current status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Shi Jinyun | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: UNKNOWN